Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease

Evaluate the Effect of Dietary Supplement Combined Supervised Exercise on Physical Performance and Body Composition Among Patients With Sarcopenia and Severe Sarcopenia Comorbid With COPD or ILD: A Prospective, Multi-center Cohort Study

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This trial is a prospective multi-center study. The purpose of this study is to evaluate the effect of dietary supplement combined with supervised exercised on the physical performance, body composition and lung function among patients with Sarcopenia and severe Sarcopenia in chronic lung disease. After participants enroll in this study, 12-week clinical trial will be conducted to analyze the improvement regarding Sarcopenia and different severity of Sarcopenia before and after the intervention of exercise and nutritional products, which can further provide reference for clinical intervention and rehabilitation.

Who May Be Eligible (Plain English)

Who May Qualify: - Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from Department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment. - Outpatients who meet the diagnostic criteria for Sarcopenia after evaluation by a physician. Who Should NOT Join This Trial: - Patients who refuse to sign the consent form - Patients who are under 20 years old - Patients who are bedridden or unable to walk due to physical disabilities - Patients with terminal cancer or human-acquired weakened immune system syndrome - Patients with edema (grading pitting edema +2) Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from Department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment. * Outpatients who meet the diagnostic criteria for Sarcopenia after evaluation by a physician. Exclusion Criteria: * Patients who refuse to sign the consent form * Patients who are under 20 years old * Patients who are bedridden or unable to walk due to physical disabilities * Patients with terminal cancer or human-acquired immunodeficiency syndrome * Patients with edema (grading pitting edema +2)

Treatments Being Tested

DIETARY_SUPPLEMENT

Sarcojoint®

All participants are administered Sarcojoint® containing leucinine 1 g, arginine 1.5 g, Vitamin D 7.5μg, chondroitin 400 mg, calcium 300 mg, and glucosamine 700 mg per package, and take 1 package twice a day.

BEHAVIORAL

supervised exercise

All participants are required to walk 6500 steps every day for 12 weeks, and the data are recorded by Xiaomi-smart-band.

Locations (1)

Taichung Veterans General Hospital
Taichung, Taiwan